Commerce Bank United Therapeutics Corp Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in United Therapeutics Corp stock. As of the latest transaction made, Commerce Bank holds 1,308 shares of UTHR stock, worth $477,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,308

Previous 1,327 1.43%

Holding current value

$477,380

Previous $422,000 10.9%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$311.04 - $363.55 $5,909 - $6,907	-19 Reduced 1.43%	1,308 $468,000
Q2 2024 Aug 12, 2024	BUY	$228.26 - $319.04 $14,152 - $19,780	62 Added 4.9%	1,327 $422,000
Q1 2024 May 03, 2024	BUY	$210.76 - $249.51 $5,058 - $5,988	24 Added 1.93%	1,265 $290,000
Q2 2023 Aug 08, 2023	SELL	$205.19 - $232.99 $8,002 - $9,086	-39 Reduced 3.05%	1,241 $273,000
Q1 2023 May 04, 2023	BUY	$212.99 - $276.17 $35,569 - $46,120	167 Added 15.0%	1,280 $286,000
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $2,677 - $3,645	13 Added 1.18%	1,113 $309,000
Q3 2022 Nov 04, 2022	SELL	$203.3 - $244.17 $12,807 - $15,382	-63 Reduced 5.42%	1,100 $230,000
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $203,304 - $280,445	1,163 New	1,163 $274,000
Q1 2022 May 09, 2022	SELL	$166.16 - $213.96 $188,923 - $243,272	-1,137 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $209,571 - $245,682	1,137 New	1,137 $246,000
Q3 2021 Nov 09, 2021	SELL	$179.86 - $214.88 $243,350 - $290,732	-1,353 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$170.47 - $211.93 $2,045 - $2,543	12 Added 0.89%	1,353 $243,000
Q1 2021 May 05, 2021	SELL	$153.94 - $174.85 $35,406 - $40,215	-230 Reduced 14.64%	1,341 $224,000
Q4 2020 Feb 09, 2021	BUY	$101.87 - $151.79 $160,037 - $238,462	1,571 New	1,571 $238,000

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account